Observed and predicted (using the Interrupted Time Series Analysis) numbers of samples during the pre- and post-intervention period, Morocco, 1996–2009.

<p>Observed and predicted (using the Interrupted Time Series Analysis) numbers of samples during the pre- and post-intervention period, Morocco, 1996–2009.</p

Onset peak and duration of influenza seasons, Morocco, 1996–2009.

<p>Onset peak and duration of influenza seasons, Morocco, 1996–2009.</p

Demographic characteristics of influenza-like illness (ILI) and severe acute respiratory illness (SARI) patients, Morocco, 2007–2009.

<p>*from September 2007 to August 2008.</p><p>**from September 2008 to August 2009.</p

Proportion of patients with laboratory-confirmed influenza by age group and surveillance network, Morocco, 2007–2009.

<p>*from September 2007 to August 2008.</p><p>**from September 2008 to August 2009.</p

Model coefficient, 95% confidence interval and p-value for the Interrupted Time-Series Regression Analysis for the assessment of the impact of the enhanced surveillance system, Morocco, 1996–2009.

<p>*the slope coefficient represent the expected average increase of number of samples in each consecutive year during the pre-intervention period (1996–2006).</p><p>**the slope coefficient represent the expected average increase of number of samples in each consecutive year during the post intervention period (2007–2009).</p

Number of positive influenza samples by type and subtypes and proportion of ILI cases over total consultation in the health unit and private clinic networks by week, Morocco, 2007–2009.

<p>Number of positive influenza samples by type and subtypes and proportion of ILI cases over total consultation in the health unit and private clinic networks by week, Morocco, 2007–2009.</p

Challenges encountered during the pandemic response in Yemen Challenges.

Challenges encountered during the pandemic response in Yemen Challenges.</p

Geographical locations of 18 laboratories with PCR, GeneXpert, and genetic sequencing capacity in Yemen by November 2022.

Geographical locations of 18 laboratories with PCR, GeneXpert, and genetic sequencing capacity in Yemen by November 2022.</p

Performance of two national-level laboratories in external quality assessment scheme.

Performance of two national-level laboratories in external quality assessment scheme.</p

Location and volumes of PCR testing performed for surveillance purpose (orange colour) and for travelers (blue) in Yemen by December 2022.

More testing happened in the southern governorates of the country where points of entry (POEs) are located, noting no positive COVID-19 cases were formally reported from the northern governorates.</p